Physician profile
Violeta Baddour
NPI 1134123037
$2,553.68
in general payments reported to CMS, 2019-2025
18 companies · $521 in 2025
The $521 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,271 · 2020: $345 · 2022: $20.08 · 2023: $43.36 · 2024: $353 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $817.30 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $571.03 | 2019-2025 | Rinvoq |
| Janssen Biotech, INC. | $352.36 | 2019-2025 | Tremfya |
| Amgen INC. | $344.96 | 2019-2025 | Krystexxa, Otezla, Tavneos |
| Glaxosmithkline, LLC. | $254.52 | 2019-2025 | Shingrix, Benlysta |
| Pfizer INC. | $201.72 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $185.80 | 2019-2025 | |
| Genentech USA, INC. | $120.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $108.26 | 2019-2024 | Orencia |
| Ucb, INC. | $79.68 | 2024-2025 | Bimzelx |
| Genzyme Corporation | $72.74 | 2019-2025 | |
| Celgene Corporation | $68.31 | 2019 | |
| Radius Health, INC. | $62.68 | 2019-2020 | |
| Sobi, INC | $35.99 | 2019-2020 | |
| Horizon Therapeutics Plc | $23.25 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.91 | 2025 | Ofev |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Invivyd INC | $20.06 | 2025 | Pemgarda |
| Kyowa Kirin, INC. | $16.71 | 2024 | Crysvita |
| Sandoz INC. | $14.15 | 2024 | Hyrimoz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Violeta Baddour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.